--- title: "Weight loss drug concept stocks performed strongly, with Hims rising 10.3%, BIIB up 4.98%, VTRX up 4" description: "Weight loss drug concept stocks performed strongly, with Hims rising 10.3%, BIIB up 4.98%, VTRX up 4.44%, Viking Therapeutics up 3.34%, Vertex Pharma up 2.87%, Amgen up 2.48%, and Pfizer up 2.31%. In " type: "news" locale: "en" url: "https://longbridge.com/en/news/239867061.md" published_at: "2025-05-12T14:19:56.000Z" --- # Weight loss drug concept stocks performed strongly, with Hims rising 10.3%, BIIB up 4.98%, VTRX up 4 > Weight loss drug concept stocks performed strongly, with Hims rising 10.3%, BIIB up 4.98%, VTRX up 4.44%, Viking Therapeutics up 3.34%, Vertex Pharma up 2.87%, Amgen up 2.48%, and Pfizer up 2.31%. In comparison, Eli Lilly saw a slight decline, Roche ADR fell 0.47%, and Novo Nordisk ADR dropped 0.91% Weight loss drug concept stocks: Hims rose 10.3%, BIIB rose 4.98%, VTRX rose 4.44%, Viking Therapeutics rose 3.34%, Vertex Pharma rose 2.87%, Amgen rose 2.48%, Pfizer rose 2.31%, Eli Lilly slightly declined, Roche ADR fell 0.47%, Novo Nordisk ADR fell 0.91% ### Related Stocks - [VKTX.US - Viking Therap](https://longbridge.com/en/quote/VKTX.US.md) - [VRTX.US - Vertex Pharma](https://longbridge.com/en/quote/VRTX.US.md) - [PFE.US - Pfizer](https://longbridge.com/en/quote/PFE.US.md) - [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md) - [RHHBY.US - Roche](https://longbridge.com/en/quote/RHHBY.US.md) - [AMGN.US - Amgen](https://longbridge.com/en/quote/AMGN.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | DELL, SPOT, UNH: The World's Biggest Hedge Fund Is Bottom Fishing the Market | Bridgewater Associates, the largest hedge fund with $136 billion in assets, made significant investments in underperform | [Link](https://longbridge.com/en/news/276384705.md) | | Why Vertex stock zoomed almost 6% higher on Thursday | The company has several juicy growth opportunities ahead of it, a market professional tracking its fortunes believes. | [Link](https://longbridge.com/en/news/276403170.md) | | Here's How Much $1000 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today | Vertex Pharmaceuticals (NASDAQ:VRTX) has delivered an average annual return of 17.22% over the past 15 years, outperform | [Link](https://longbridge.com/en/news/276269422.md) | | IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio | Specialty healthcare ETFs can enhance investment portfolios by focusing on distinct sectors like pharmaceuticals, medica | [Link](https://longbridge.com/en/news/276080275.md) | | $100 Invested In Viking Therapeutics 10 Years Ago Would Be Worth This Much Today | Viking Therapeutics (NASDAQ:VKTX) has delivered an annualized return of 33.01% over the past decade, outperforming the m | [Link](https://longbridge.com/en/news/276347002.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.